Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data
Chatziralli, I, Santarelli, M, Patrao, N, Nicholson, L, Zola, M, Rajendram, R, Hykin, P, Sivaprasad, SLanguage:
english
Journal:
Eye
DOI:
10.1038/eye.2017.111
Date:
June, 2017
File:
PDF, 153 KB
english, 2017